← FDA Drug Approvals (Drugs@FDA)
METHOCARBAMOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MIKART · Approved 2023-06-12
Drug application
- FDA Application #
ANDA212707- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHOCARBAMOL
- Generic name
- METHOCARBAMOL
- Active ingredients
- METHOCARBAMOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MIKART
- Manufacturer
- FH2 PHARMA LLC
- First approval
- 2023-06-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown